Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nasal Packing with Dexmedetomidine, Midazolam, or Bupivacaine in FESS
NCT07013955Phase 3Enrolling by invitation
- Sponsor
- Minia University
- Start
- Apr 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine, midazolam, bupivacaine hydrochloride 0.75% injection in paranasal sinus disease, sponsored by Minia University. Started Apr 2025; status: enrolling by invitation.
02
Drugs
dexmedetomidinemidazolambupivacaine hydrochloride 0.75% injection
03
Conditions
paranasal sinus disease
Beyond the preview
Go deeper on NCT07013955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07013955.